Bacterial pathogens and outcome determinants of childhood pyogenic meningitis in Ilorin, Nigeria
- PMID: 14510107
Bacterial pathogens and outcome determinants of childhood pyogenic meningitis in Ilorin, Nigeria
Abstract
Empirical antimicrobial therapy remainsjustifiable in childhood pyogenic meningitis (CPM), but the continuing efficacy in a particular setting requires periodic microbiological surveillance. It was this need that informed the present five-year retrospective study of consecutive admissions for CPM at the Emergency Paediatric Unit (EPU) of the University of Ilorin Teaching Hospital, Ilorin, Nigeria. Of the 71 cerebro-spinal fluid [CSF] analyses, 41 (57.6%) were Gram-smear positive (GSP). Gram-positive cocci (GPC) were identified in 23 (56.1%) smears, while 14 (34.2.%) had Gram-negative bacilli (GNB). Only three (7.3%) had Gram-negative diplococci (GND). Despite corroborative biochemical findings, the remaining 30 (42.3%), including two with tuberculous meningitis proved smear-negative. GPC cases had a mean age of 4.49 +/- 5.3yrs, GNB, 3.06 +/- 4.8yrs and GND, 4.47 +/- 4.9yrs. CSF isolates were made in 28 (39.4%) cases. Streptococcus pneumoniae accounted for a predominant 22 (78.6%) (P = 0.00), Haemophilus influenzae for 2 (7.1%), and Neisseria meningitidis for only 1 (3.5%) case. Whereas Strept. pneumoniae and H. influenzae isolates were uniformly sensitive to each of sultamicillin, cefuroxime, ceftriaxone and ceftazidime, 7.7% of Strept. pneumoniae were resistant to crystalline penicillin, 6.7% to ampicillin, and 69.2% to chloramphenicol; one of the two H. influenzae isolates was chloramphenicol-resistant. Amongst the 30 (42.3%) fatal cases, the length of stay was significantly shorter in GNB-positive cases (P = 0.045). Mortality was significantly higher amongst cases with purulent/turbid CSF at admission (P = 0.03), and in those with CSF protein of >150mg/dl (P = 0.02) and glucose <1mg/dl (P = 0.047). The present aetiological preponderance of GPC and Strept. pneumoniae in our study population, the high case-fatality, and the emerging resistance profile suggest the need for exploring additional control options including vaccination. We emphasize the need for periodic auditing of local antimicrobial policies in CPM.
Similar articles
-
Childhood pyogenic meningitis: clinical and investigative indicators of etiology and outcome.J Natl Med Assoc. 2007 Aug;99(8):937-47. J Natl Med Assoc. 2007. PMID: 17722674 Free PMC article.
-
Bacterial profile and clinical outcome of childhood meningitis in rural Yemen: a 2-year hospital-based study.J Infect. 2006 Oct;53(4):228-34. doi: 10.1016/j.jinf.2005.12.004. Epub 2006 Jan 23. J Infect. 2006. PMID: 16434101
-
Antimicrobial susceptibility of cerebrospinal isolates from patients with meningitis.Neuro Endocrinol Lett. 2007 Nov;28 Suppl 3:5-6. Neuro Endocrinol Lett. 2007. PMID: 18030262
-
Childhood bacterial meningitis beyond the neonatal period in southern Nigeria: changes in organisms/antibiotic susceptibility.East Afr Med J. 1994 Jan;71(1):14-20. East Afr Med J. 1994. PMID: 8055756 Review.
-
Aetiology of bacterial meningitis and resistance to antibiotics of causative pathogens in Europe and in the Mediterranean region.Int J Antimicrob Agents. 2007 Jun;29(6):621-9. doi: 10.1016/j.ijantimicag.2006.11.031. Epub 2007 Mar 26. Int J Antimicrob Agents. 2007. PMID: 17368858 Review.
Cited by
-
Global Case Fatality of Bacterial Meningitis During an 80-Year Period: A Systematic Review and Meta-Analysis.JAMA Netw Open. 2024 Aug 1;7(8):e2424802. doi: 10.1001/jamanetworkopen.2024.24802. JAMA Netw Open. 2024. PMID: 39093565 Free PMC article.
-
Epidemiological, clinical and prognostic profile of childhood acute bacterial meningitis in a resource poor setting.J Neurosci Rural Pract. 2015 Oct-Dec;6(4):549-57. doi: 10.4103/0976-3147.165424. J Neurosci Rural Pract. 2015. PMID: 26752902 Free PMC article.
-
Sex differences in bacterial meningitis and associations with socioeconomic indicators: a systematic review and meta-analysis with metaregression.BMJ Glob Health. 2025 Apr 30;10(4):e016802. doi: 10.1136/bmjgh-2024-016802. BMJ Glob Health. 2025. PMID: 40306729 Free PMC article.